Midline Catheter Market Overview

The Global Midline Catheter Market is witnessing strong growth, driven by the increasing use of minimally invasive devices for intravenous therapy, the rising prevalence of chronic illnesses requiring long-term IV medication, and growing hospital admissions worldwide. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 5.4 billion by 2033, expanding at a CAGR of 7.4% during the forecast period.

Midline catheters are vascular access devices inserted into peripheral veins, typically in the upper arm, to provide medium-term access for intravenous therapy lasting between 1 to 4 weeks. These catheters are less invasive than peripherally inserted central catheters (PICCs) and present fewer risks of complications such as thrombosis and infections, making them increasingly favored in clinical settings. The demand for midline catheters is rising as healthcare providers focus on reducing hospital-acquired infections (HAIs) and enhancing patient safety. Advancements in catheter design and biocompatible materials such as polyurethane and silicone are further fueling adoption. Additionally, the growing preference for outpatient care, ambulatory surgical centers, and home infusion therapy is expanding the scope of midline catheter applications. With rising investments in healthcare infrastructure and innovation in catheter kits, the market is poised for sustained growth.

Midline Catheter Market Drivers and Opportunities

The rising prevalence of chronic diseases and the growing need for IV therapies are expected to drive the midline catheter market

The global burden of chronic diseases such as cancer, diabetes, cardiovascular disorders, and renal failure is creating a substantial demand for intravenous therapies, thereby fueling the adoption of midline catheters. Unlike traditional peripheral IV lines that require frequent replacement, midline catheters provide reliable venous access for up to four weeks, reducing the need for multiple insertions and improving patient comfort. Hospitals and specialty clinics are increasingly adopting midline catheters to reduce infection rates and costs associated with central venous catheters. Additionally, the rise in chemotherapy, parenteral nutrition, and antibiotic therapy is driving demand. The aging population, particularly in North America, Europe, and parts of the Asia-Pacific, is more prone to chronic illnesses requiring extended treatment cycles. This demographic trend directly translates into higher usage of midline catheters across healthcare systems. With healthcare providers seeking cost-effective yet safe solutions for vascular access, midline catheters are positioned as an optimal choice for medium-term IV therapy.

Technological advancements in catheter materials and design are boosting market adoption

Innovation in catheter design and material science is significantly enhancing the performance and safety profile of midline catheters. Manufacturers are increasingly using polyurethane and silicone due to their biocompatibility, flexibility, and resistance to kinking or clotting. Advanced coatings that reduce microbial colonization are improving infection control, making midline catheters safer for patients requiring prolonged therapy. Furthermore, the introduction of catheter kits that include insertion accessories, securement devices, and antimicrobial dressings is streamlining the process for clinicians and reducing procedural complications. Many healthcare facilities are standardizing catheter kits to ensure efficiency and consistency in insertion practices. Additionally, integration of ultrasound-guided insertion techniques is improving placement accuracy, reducing the risk of complications, and enhancing overall adoption rates. These technological developments are making midline catheters more attractive to hospitals, ambulatory surgical centers, and even home-care settings.

Opportunity for the Midline Catheter Market

Growing demand for outpatient care and home infusion therapy presents significant opportunities

Healthcare delivery models are shifting toward outpatient care and home-based treatment, driven by the need to reduce healthcare costs, hospital overcrowding, and patient readmission rates. Midline catheters are particularly well-suited for home infusion therapy due to their ease of use, reduced infection risks compared to central lines, and suitability for therapies such as hydration, antibiotics, and pain management. Ambulatory surgical centers (ASCs) and specialty clinics are also increasingly using midline catheters for post-surgical care and medium-term IV therapy. The rise in telemedicine and remote patient monitoring further complements the use of midline catheters in home settings, enabling clinicians to track therapy progress while minimizing hospital visits. As healthcare systems worldwide expand outpatient and home care infrastructure, opportunities for midline catheter manufacturers to cater to these settings are expected to grow significantly.

Midline Catheter Market Scope

Midline Catheter Market Report Segmentation Analysis

The global Midline Catheter Market industry analysis is segmented by design, by product type, by material, by end-use, and by region.

The Midline Catheter segment accounted for the largest market share in the global Midline Catheter market

By product type, the market is divided into segments such as Midline Catheter and Midline Catheter Kit. The Midline Catheter segment accounted for a 64.5% share in the global market in 2025. This dominance is primarily attributed to the widespread use of midline catheters in hospitals and ambulatory surgical centers for short- to medium-term intravenous therapies, typically ranging from one to four weeks. Their ability to reduce the need for repeated peripheral IV insertions and minimize complications such as phlebitis and infiltration drives their adoption. Midline catheters are increasingly preferred in managing patients with chronic infections, those requiring prolonged antibiotic treatments, and individuals needing parenteral nutrition. Additionally, technological advancements in catheter design, such as antimicrobial coatings and improved biocompatible materials, further enhance their safety and reliability, solidifying their strong market position. On the other hand, midline catheter kits are gaining momentum due to their convenience in clinical practice, but their share remains smaller compared to standalone catheters. The growing demand for efficient and cost-effective IV access solutions continues to ensure the midline catheter segment’s leadership in the market. 

The Single Lumen segment accounted for the largest market share in the global Midline Catheter market

By design, the market divides into segments such as Single Lumen and Double Lumen. Single lumen catheters dominate the segment, as they are widely used for administering intravenous fluids, antibiotics, and other medications in patients requiring medium-term access. Their simplicity, reduced insertion-related complications, and lower cost make them the preferred choice for routine clinical use. They are particularly valuable in settings where patients require limited infusion therapy or single-drug administration, minimizing risks associated with multiple-lumen devices. Double-lumen catheters, though less commonly used, are gaining adoption for patients who need simultaneous administration of incompatible drugs or infusion therapies.

The Polyurethane segment accounted for the largest market share in the global Midline Catheter market

By material, the market is divided into segments such as Polyurethane and Silicone. Polyurethane catheters are extensively preferred due to their superior mechanical strength, flexibility, and ability to withstand long-term use compared to silicone variants. Their thin walls allow for a larger internal diameter, improving flow rates and making them suitable for a wide range of infusion therapies. Additionally, polyurethane’s durability reduces the chances of catheter breakage, leakage, or collapse, enhancing patient safety and healthcare efficiency. Silicone catheters, although biocompatible and softer, are more fragile and are prone to kinking, which can limit their usage in high-volume fluid administration.

The following segments are part of an in-depth analysis of the global Midline Catheter Market:

Midline Catheter Market Share Analysis by Region

The North America region is projected to hold the largest share of the global Midline Catheter market over the forecast period.

The global midline catheter market shows significant regional variation, with North America accounting for the largest share due to high healthcare spending, advanced hospital infrastructure, and early adoption of innovative catheter technologies. The U.S. leads the region, supported by a high prevalence of chronic illnesses, increasing outpatient care, and robust investments in infection control measures. Europe follows closely, driven by an aging population and growing demand for home infusion therapies. Countries such as Germany, France, and the U.K. are key contributors.

The Asia-Pacific region is expected to grow at the fastest CAGR, fueled by rising healthcare expenditure, expanding hospital networks, and greater awareness about vascular access devices in countries like China and India. Latin America and the Middle East & Africa are also seeing steady growth as healthcare infrastructure improves and the burden of chronic diseases rises. Overall, while developed regions dominate in terms of revenue, emerging economies represent high-growth opportunities for manufacturers.

Midline Catheter Market Competition Landscape Analysis

The global midline catheter market is moderately consolidated, with leading players focusing on product innovation, strategic collaborations, and expansion into emerging markets. Companies are investing in advanced materials, antimicrobial coatings, and user-friendly kits to strengthen their portfolios. Key players in the market include BD (Becton, Dickinson and Company), Teleflex Incorporated, AngioDynamics, Cook Medical, Vygon SA, Smiths Medical, and B. Braun Melsungen AG. These firms are also leveraging training programs and partnerships with hospitals to expand adoption and reinforce their competitive edge.

Global Midline Catheter Market Recent Developments News:

• In May 2025 – SkyDance Vascular received U.S. FDA 510(k) clearance for its Osprey Midline Closed IV Catheter System, an advanced extended-dwell catheter designed to improve patient safety and clinical outcomes in peripheral intravenous catheter (PIVC) procedures through reduced complications and enhanced usability.

• In February 2024 – AngioDynamics, Inc. finalized the sale of its peripherally inserted central catheter (PICC) and midline catheter portfolios to Spectrum Vascular, streamlining its focus on core vascular access and oncology interventions while transitioning these product lines to a dedicated specialist.

• In June 2022 – Teleflex Incorporated launched the Arrow Pressure Injectable Midline Catheter across Europe, the Middle East, and Africa (EMEA), expanding its vascular access portfolio with a solution engineered to improve patient safety, procedural efficiency, and resilience under pressure during IV therapies.

The Global Midline Catheter Market is dominated by a few large companies, such as

●        Becton, Dickinson and Company (BD)

●        B. Braun Melsungen AG

●        Teleflex Incorporated

●        AngioDynamics

●        Smiths Medical (ICU Medical)

●        Vygon

●        Cook Medical

●        Argon Medical Devices

●        Protea Medical

●        Medical Components, Inc. (Medcomp)

●        Amecath

●        Vigmed

●        Romsons

●        Vogt Medical

●        RENUÂ Medical

●        Other Prominent Players